Failure of Osseointegrated Dental Implants After Diphosphonate Therapy for Osteoporosis: a Case Report
Overview
Authors
Affiliations
Late loss of initially integrated endosseous implants has generally been attributed to implant overload often the result of inappropriate prosthesis design. Implant placement is rarely contraindicated by preexisting systemic diseases, and no instances of medication-induced implant failure have been reported in the literature. This paper reports a case in which a patient lost five endosseous implants that had successfully osseointegrated and had been restored with a lower hybrid prosthesis approximately 6 months after diphosphonate therapy for osteoporosis was started.
Clinical outcome of narrow diameter dental implants: a 3-year retrospective study.
Kim J, Yoon Y, Pae A, Kwon Y Maxillofac Plast Reconstr Surg. 2023; 45(1):26.
PMID: 37526800 PMC: 10393933. DOI: 10.1186/s40902-023-00394-6.
[Bisphosphonate-related osteonecrosis of the jaw caused by implant: a case report].
Wu P, Li Y, Lei Z, Chen L Hua Xi Kou Qiang Yi Xue Za Zhi. 2020; 38(4):460-463.
PMID: 32865369 PMC: 7426673. DOI: 10.7518/hxkq.2020.04.019.
A rare case of bevacizumab-related osteonecrosis of the jaw associated with dental implants.
Maluf G, Caldas R, Fregnani E, Santos P Int J Implant Dent. 2019; 5(1):34.
PMID: 31571065 PMC: 6768921. DOI: 10.1186/s40729-019-0188-0.
Frizzera F, Verzola M, de Molon R, de Oliveira G, Giro G, Spolidorio L Clin Oral Investig. 2018; 23(4):1733-1744.
PMID: 30159806 DOI: 10.1007/s00784-018-2612-x.
Zhang J, Park J, Lee J, Kwon Y, Kim E Clin Oral Investig. 2017; 22(5):1933-1943.
PMID: 29188452 DOI: 10.1007/s00784-017-2291-z.